Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in VCYT — Veracyte, Inc.

CIK 1115418 BOSTON, MA
Back to VCYT Full portfolio

Position in VCYT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$11,097,150
+$4,228,883 QoQ
Shares Held
188,952
-11.4% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#59
of 367 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,233,577,400 across 30 Diagnostics & Research names. VCYT ranks #17 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 593,946 $297,780,766
2 DHR
Danaher Corp /De/
 995,923 $189,703,413
3 ILMN
Illumina, Inc.
 560,716 $98,590,694
4 IDXX
Idexx Laboratories Inc /De
 169,208 $89,077,859
5 A
Agilent Technologies, Inc.
 500,807 $66,522,193
6 IQV
Iqvia Holdings Inc.
 332,138 $64,175,704
7 WAT
Waters Corp /De/
 168,771 $63,295,875
8 DGX
Quest Diagnostics Inc
 267,727 $56,744,737

All Filings in VCYT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,097,150 188,952
2026-03-31 $6,868,267 213,234
2025-12-31 $8,887,773 211,111
2025-09-30 $7,628,194 222,202
2025-06-30 $3,231,409 119,549
2025-03-31 $3,571,461 120,454
2024-12-31 $4,883,630 123,324
2024-09-30 $4,174,971 122,649
2024-06-30 $2,790,532 128,774
2024-03-31 $2,674,224 120,678
2023-12-31 $3,244,309 117,932
2023-09-30 $2,643,403 118,379
2023-06-30 $2,968,426 116,546
2023-03-31 $2,606,089 116,865
2022-12-31 $2,728,095 114,964
2022-09-30 $1,850,169 111,456
2022-06-30 $2,095,609 105,307
2022-03-31 $2,452,930 88,971
2021-12-31 $3,975,017 96,481
2021-09-30 $4,534,913 97,630
2021-06-30 $3,824,966 95,672
2021-03-31 $3,745,515 69,684
2020-12-31 $3,432,504 70,137
2020-09-30 $2,138,101 65,808
2020-06-30 $1,870,005 72,201
2020-03-31 $1,570,790 64,615